It has been studied that synthetic mammography from digital breast tomosynthesis radiomics signature could discriminate TN, HER2, and luminal subtypes of breast cancer, which yielded an AUC of 0.838, 0.556, and 0.645, respectively, in the validation cohort (25). The gene discussed is ERBB2; the disease is breast carcinoma.